Safacto AF Injection 500IU Price In Pakistan

Safacto AF Injection 500IU Price In Pakistan

Safacto AF Injection 500IU is a prescription medicine containing recombinant Factor VIII (coagulation factor VIII). It is used to treat and help prevent bleeding episodes in people with Hemophilia A, a condition in which the body does not produce enough functional clotting factor VIII.

Safacto AF works by replacing the missing clotting factor, helping the blood form clots and control bleeding. It is manufactured by Saman Darou 8 and is supplied as a lyophilized powder that must be prepared before administration.

Key Benefits

• Helps control bleeding episodes associated with Hemophilia A.

• Replaces deficient Factor VIII to support normal blood clotting.

• May be prescribed to prevent bleeding episodes as part of a regular treatment plan.

• Can be used under specialist supervision for bleeding management around certain surgical procedures.

• Supports the management of congenital Factor VIII deficiency.

Treatment outcomes depend on the patient's condition and response to therapy.

Ingredients

• Active Ingredient: Recombinant human coagulation Factor VIII — 500 International Units (IU).

• Other Ingredients: The exact excipients and supplied solvent should be confirmed from the product packaging or manufacturer's leaflet.

Do not assume that the inactive ingredients of other Factor VIII brands are identical to those of Safacto AF.

Specifications

• Brand Name: Safacto AF

• Generic Name: Recombinant Coagulation Factor VIII

• Strength: 500 IU

• Dosage Form: Lyophilized powder for solution for injection

• Route of Administration: Intravenous (IV)

• Drug Class: Coagulation factor replacement

• Primary Use: Treatment and prevention of bleeding in Hemophilia A

• Manufacturer: Saman Darou 8

• Prescription Required: Yes

• Availability in Pakistan: Confirm current stock, authenticity, and price with a licensed pharmacy.

How To Use

1. Use Safacto AF only as prescribed by a hematologist or another qualified specialist.

2. The powder must be reconstituted with the correct supplied solvent according to the manufacturer's instructions.

3. The prepared solution is administered intravenously by a trained healthcare professional or by a patient/caregiver specifically trained in the technique.

4. The dose depends on body weight, the severity and location of bleeding, Factor VIII levels, and the treatment goal.

5. Do not use the product if the vial is damaged, expired, or the reconstituted solution looks abnormal.

6. Follow the product-specific storage instructions and do not reuse leftover solution unless the leaflet explicitly permits it.